The Uncovered Role of Interferons in Sepsis: From Pathogenesis to Precision Immunotherapy
Open Access
- 14 August 2026
- journal article
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
Abstract
Sepsis is a life-threatening syndrome characterized by a dysregulated host response to infection resulting in organ dysfunction. While traditional paradigms have emphasized proinflammatory cytokines, such as tumor necrosis factor-α and interleukin-1β, interferons (IFNs) are increasingly recognized as critical yet underexplored mediators of sepsis pathobiology. IFNs are central regulators of innate and adaptive immunity and have emerged as key mediators of the immune alterations observed during sepsis. Type I IFNs (IFN-α/β), type II IFN (IFN-γ), and type III IFNs exert pleiotropic effects on immune activation, pathogen clearance, endothelial function, immunometabolism, and tissue injury. While early IFN responses support antimicrobial defense, sustained or dysregulated signaling contributes to hyperinflammation, endothelial dysfunction, immune exhaustion, coagulopathy, and multiorgan failure. Increasing evidence from experimental models and clinical studies suggests that IFN activity differs substantially among septic patients and may define biologically distinct immune endotypes. IFN-stimulated gene signatures and IFN-related biomarkers therefore represent promising tools for patient stratification and precision immunotherapy. This review summarizes the biology of IFNs relevant to sepsis, their role across different disease phases, their contribution to organ dysfunction, and emerging therapeutic strategies targeting IFN pathways. Current evidence supports a shift toward biomarker-guided and phase-specific immunomodulation aimed at restoring immune homeostasis while minimizing harmful inflammation.Keywords
This publication has 70 references indexed in Scilit:
- Precision Immunotherapy to Improve Sepsis OutcomesJAMA, 2026
- Integrated transcriptomic and proteomic profiling identifies an interferon-dependent inflammatory endotype in sepsisBiomedicine & Pharmacotherapy, 2026
- Temporal robustness of biomarker-based classification algorithms for sepsisIntensive Care Medicine, 2025
- Pharmacological inhibition of STING-mediated GPX4 autophagic degradation by 4-octyl itaconate ameliorates sepsis-induced acute kidney injuryApoptosis, 2025
- Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsisIntensive Care Medicine, 2024
- Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trialIntensive Care Medicine, 2023
- Interferon Type I Regulates Inflammasome Activation and High Mobility Group Box 1 Translocation in Hepatocytes During Ehrlichia -Induced Acute Liver InjuryHepatology Communications, 2020
- Identification of new type I interferon-stimulated genes and investigation of their involvement in IFN-β activationProtein & Cell, 2018
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011